Aurobindo Pharma is presently trading at Rs. 790.00, up by using eleven.25 points or 1.44% from its preceding final of Rs. 778.Seventy five on the BSE.

The scrip opened at Rs. 790.00 and has touched a excessive and low of Rs. 790.00 and Rs. 780.50 respectively.

The BSE group ‘A’ inventory of face price Rs. 1 has touched a 52 week excessive of Rs. 830.00 on 04-Dec-2018 and a fifty two week low of Rs. 527.05 on 04-Jun-2018.

Last one week high and occasional of the scrip stood at Rs. 804.Seventy five and Rs. 737.05 respectively. The present day marketplace cap of the corporation is Rs. 45627.Fifty six crore.

The promoters conserving in the agency stood at fifty one.87%, while Institutions and Non-Institutions held 34.Fifty one% and 13.62% respectively.

Aurobindo Pharma has entered right into a proportion subscription settlement to invest Rs 15 crore in Synergy Remedies, a Tirupathi primarily based Pharma Company by means of subscribing to extra equity stocks of the stated organisation. After making the stated investment, the Company could be conserving 19.9% of the proportion capital of Synergy.